Bradley C. Martin

Dr. Bradley C. Martin is Professor and founding head of the Pharmaceutical Evaluation and Policy (PEP) Division at the University of Arkansas for Medical Sciences College of Pharmacy. With over two decades of experience, he teaches graduate courses in real-world evidence and cost-effectiveness modeling while advising 10 Ph.D. and 12 M.S. students. His research leverages large administrative datasets to advance pharmaceutical policy and opioid epidemic understanding.

Dr. Martin's educational background includes:

• Pharm.D. from the University of Illinois Chicago (1989)
• Ph.D. in Pharmacy Care Administration from the University of Georgia (1993)

His research spans opioid use disorders, pharmaceutical policy analyses, and pharmacoepidemiology using large administrative databases. He pioneered studies on acute-to-chronic opioid transition patterns that directly influenced U.S. policy, while developing cost-effectiveness models and risk adjustment methodologies for healthcare decision-making. His work integrates burden of illness studies with real-world evidence generation.

Dr. Martin's scientific awards include:

• Arcansas HealthCare Heroes, Health Professional Hero of the Year (2019)
• Multiple ISPOR Distinguished Service Awards (2012-2016)
• Exceptional Reviewer honors from JMCP (2013, 2017, 2019) and Journal of Pharmacoepidemiology and Drug Safety (2012)
• ASHP Foundation Pharmacy Practice Research Award (2003)
• AFPE Fellow designation (2004)
• Arkansas College of Clinical Pharmacy Investigator Award (2016)

He has advised 22 graduate students and secured research funding from NIH, AHRQ, VA, DOJ, research foundations, and pharmaceutical industry partnerships. Dr. Martin leads international initiatives through ISPOR, NPC, and AMCP to improve observational research standards and serves on ICER's Midwest Comparative Effectiveness Public Advisory Council for evidence-based clinical decision guidance.